Immunotherapy Study for Metastatic Renal Cell Cancer

Clinical trial NCT02035358 · COMPLETED

Trial details

NCT number: NCT02035358
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Metastatic Clear-cell Renal Cancer Recurrent Renal Cell Carcinoma Refractory Renal Cell Carcinoma Metastatic Kidney Cancer

Start date: 2015-05-01
Primary completion: 2017-01-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.